|Last Price$180.26||Day Change (%)-0.18%|
|Open Price$175.80||Day Change ($)-0.33|
|Day Range178.31–183.73||52-Week Range136.37–203.30|
As of Mon 3/30/2015 5:00:00 PM | USD
New Data from First Natural History Study in Juveniles with Hypophosphatasia (HPP) Showing Substantial Disease Burden, Including Musculoskeletal Abnormalities and Growth Deficiencies, Presented in Late-Breaking Oral Session at ENDO 2015
Research and Markets: Myasthenia Gravis Therapeutics Pipeline Review H1 2015
Research and Markets: Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts'
Research and Markets: Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success
We crunch the numbers to see which stocks are most widely held among analyst-recommended large-cap funds.
Ownership data provide a look at who else owns the company.
Standing out in a good year for stocks.